Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.

In a recent video spot, the 43-year-old athlete reveals that Ro helped her lose 31 pounds in eight months. “Yes, I’m on Ro.

Health insurance will grow more expensive in many corners of the market in 2026, and some coverage may shrink.

Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a ...

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...

Celebrities have access to doctors that most others don’t,” Jameela Jamil flags the risks of GLP-1s like those Serena ...

Jameela Jamil is clarifying her previous statement regarding Serena Williams and GLP-1s. Here's what she said.

About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...

Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it next year.

Eli Lilly and Novo Nordisk already make popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site will, too.